LabGenius Company

LabGenius develops next-generation protein therapeutics using a machine learning-driven evolution engine (EVA). They use robotic automation, synthetic biology and advanced machine learning to explore protein fitness landscapes and improve multiple drug properties simultaneously.

Connections

Technology: Early drug development
Industry: Drug Discovery
Headquarters: UK
Founded Date: 2012

Visit Website
twitter.com/labgeni_us
Register and Claim Ownership